• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 5. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735

Introduction to 2-(carboxyformamido)propanoic acid (CAS No. 141635-12-3)

2-(carboxyformamido)propanoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 141635-12-3, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and bioorganic synthesis. This compound belongs to a class of molecules characterized by the presence of both carboxylic acid and formamido functional groups, which confer unique reactivity and potential biological activity. The structural motif of 2-(carboxyformamido)propanoic acid makes it a versatile intermediate in the synthesis of more complex molecules, particularly in the development of novel therapeutic agents.

The significance of this compound lies in its utility as a building block in medicinal chemistry. The presence of both a carboxylic acid group and a formamido moiety allows for diverse chemical modifications, enabling the construction of peptidomimetics, protease inhibitors, and other pharmacologically relevant scaffolds. Recent advancements in synthetic methodologies have further highlighted the importance of 2-(carboxyformamido)propanoic acid as a key precursor in the preparation of bioactive molecules.

In recent years, researchers have been exploring the potential applications of 2-(carboxyformamido)propanoic acid in the development of targeted therapies. For instance, its structural features make it an attractive candidate for designing inhibitors of enzymes involved in inflammatory pathways. Studies have demonstrated that derivatives of this compound can modulate the activity of key enzymes such as cyclooxygenases (COX) and lipoxygenases, which are pivotal in the regulation of inflammatory responses. The ability to fine-tune the pharmacophoric properties through structural modifications has opened up new avenues for drug discovery.

Moreover, the formamido group in 2-(carboxyformamido)propanoic acid provides a site for further functionalization, allowing chemists to introduce additional pharmacological moieties. This flexibility has been exploited in the design of peptidomimetics that mimic the natural substrate binding pockets of enzymes. Such mimetics are particularly valuable in developing treatments for diseases where enzyme inhibition is a viable strategy. The compound’s role as a scaffold for peptidomimetic design has been further underscored by its incorporation into libraries for high-throughput screening (HTS), enabling rapid identification of lead compounds with desired biological activity.

The synthesis of 2-(carboxyformamido)propanoic acid itself is an area of active research. Modern synthetic approaches have focused on optimizing yield and purity while minimizing environmental impact. Catalytic methods, including transition-metal-catalyzed reactions, have been employed to enhance efficiency. These advancements not only improve the accessibility of the compound but also align with broader trends toward sustainable chemistry practices. The development of greener synthetic routes ensures that 2-(carboxyformamido)propanoic acid can be produced responsibly, supporting both academic research and industrial applications.

From a computational chemistry perspective, 2-(carboxyformamido)propanoic acid has been studied to understand its molecular interactions and binding affinities. Molecular docking simulations have been used to predict how this compound might bind to target proteins, providing insights into its potential as a drug candidate or tool compound. These computational studies are complemented by experimental validation, where kinetic studies and X-ray crystallography are employed to elucidate structural details at an atomic level.

The growing interest in 2-(carboxyformamido)propanoic acid is also reflected in its incorporation into academic and industrial research programs. Collaborative efforts between universities and pharmaceutical companies have led to innovative applications, including its use as a starting material for synthesizing novel antibiotics and antiviral agents. The compound’s ability to serve as a precursor for structurally diverse molecules underscores its importance in modern drug discovery pipelines.

Future directions for research on 2-(carboxyformamido)propanoic acid may include exploring its role in addressing emerging therapeutic challenges, such as antibiotic resistance or neurodegenerative diseases. By leveraging its unique structural features, scientists aim to develop next-generation therapeutics that offer improved efficacy and reduced side effects compared to existing treatments. The continued investigation into this compound promises to yield valuable insights into molecular recognition processes and contribute to advancements across multiple disciplines within chemical biology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)